Phase 2b trial results of padeliporfin (WST11 or Tookad) vascular-targeted photodynamic therapy for partial gland ablation in men with intermediate-risk prostate cancer Meeting Abstract
| Authors: | Coleman, J.; Sjoberg, D. D.; Demac, Q.; ODea, C.; McGill, M.; Tracey, A.; Nogueira, L.; Vickers, A.; Estes, C.; Fine, S.; Akin, O.; Mulhall, J.; Sandhu, J.; Carver, B. S.; Laudone, V. P.; Ehdaie, B.; Scherz, A. J.; Scardino, P. T.; Eastham, J. A. |
| Abstract Title: | Phase 2b trial results of padeliporfin (WST11 or Tookad) vascular-targeted photodynamic therapy for partial gland ablation in men with intermediate-risk prostate cancer |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120302279 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.e17006 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: e17006 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
